- Study: Whooping cough vaccine may not prevent infection
- Chickenpox vaccine does not appear to increase incidence of shingles, study finds
- Study: Pharmacist intervention improves shingles vaccine rate
- At least 23,000 die from antibiotic-resistant infections each year, CDC finds
- Bydureon pen gets FDA approval
SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a generic antibiotic, the company said.
The generic drug maker announced the launch of oxacillin for injection. The drug is a semi-synthetic penicillin used to treat infections caused by penicillinase-producing staphylococci bacteria that have demonstrated susceptibility to the drug.
The drug had sales of $29 million during the 12-month period ended in May, according to IMS Health.